Skip to main content
. 2022 Oct 4;328(13):1326–1335. doi: 10.1001/jama.2022.16844

Table 1. Baseline Characteristics.

Characteristics No. (%) of patients
Opioid-sparing protocol (n = 95) Standard care (n = 98)
Age, mean (SD), y 42.3 (15.2) 43.0 (15.3)
Sex
Men 62 (65.3) 58 (59.2)
Women 33 (34.7) 40 (40.8)
BMI
Mean (SD) 29.1 (6.3) 29.3 (6.8)
Underweight <18.5 1 (1.1) 0
Normal weight 18.5 to <25 27 (28.4) 28 (28.6)
Overweight 25 to <30 32 (33.7) 32 (32.7)
Obese 30 to <40 31 (32.6) 35 (35.7)
Morbidly obese ≥40 4 (4.2) 3 (3.1)
Use of tobacco products
None 78 (82.1) 82 (83.7)
Current smoker 13 (13.7) 8 (8.2)
Previous smoker 4 (4.2) 8 (8.2)
Alcohol consumption
None 33 (34.7) 35 (35.7)
Yes, <5 drinks/wk 43 (45.3) 35 (35.7)
Yes, ≥5 drinks/wk 19 (20.0) 28 (28.6)
Sport activity level prior to injury
None 7 (7.4) 6 (6.1)
Light 17 (17.9) 18 (18.4)
Moderate 30 (31.6) 44 (44.9)
Vigorous 41 (43.2) 30 (30.6)
Comorbidities
Back pain 16 (16.8) 11 (11.2)
Asthma 6 (6.3) 10 (10.2)
Depression 3 (3.2) 12 (12.2)
Diabetes 3 (3.2) 4 (4.1)
Osteoporosis 2 (2.1) 3 (3.1)
Anxiety 0 2 (2.0)
Hypertension 1 (1.1) 1 (1.0)
Posttraumatic stress disorder 0 2 (2.0)
Ulcers 1 (1.1) 1 (1.0)
Othera 7 (7.4) 5 (5.1)
Employment status
Employed 66 (69.5) 72 (73.5)
Retired 12 (12.6) 11 (11.2)
Student 9 (9.5) 11 (11.2)
Not employed, other 8 (8.4) 4 (4.1)

Abbreviation: BMI, body mass index, calculated as weight in kilograms divided by height in meters squared.

a

One patient (1.0%) each in one treatment group: Lyme disease, multiple sclerosis, neck pain, polycystic ovarian syndrome, and obstructive sleep apnea. The following comorbidities were reported by 1 patient (1.1%) each in the other treatment group: anemia, cancer, B12 deficiency, fibroids, irritable bowel syndrome, hypoglycemia, and Parkinson disease.